Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes

NCT07772960 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT07772960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07772960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
October 31, 2031
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder (aud), obesity (bmi equal to or >30)